Jg. Herman et al., SILENCING OF THE VHL TUMOR-SUPPRESSOR GENE BY DNA METHYLATION IN RENAL-CARCINOMA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(21), 1994, pp. 9700-9704
Mutational inactivation and allelic loss of the von Hippel-Lindan (VHL
) gene appear to be causal events for the majority of spontaneous clea
r-cell renal carcinomas. We now show that hypermethylation of a normal
ly unmethylated CPG island in the 5' region provides another potential
ly important mechanism for inactivation of the VHL gene in a significa
nt portion of these cancers. This hypermethylation was found in 5 of 2
6 (19%) tumors examined. Four of these had lost one copy of VHL while
one retained two heavily methylated alleles. Four of the tumors with V
HL hypermethylation had no detectable mutations, whereas one had a mis
sense mutation in addition to hypermethylation of the single retained
allele. As would be predicted for the consequence of methylation in th
is 5' CpG island, none of the 5 tumors expressed the VHL gene. In cont
rast, normal kidney and all tumors examined with inactivating VHL gene
mutations but no CpG island methylation had expression. In a renal ce
ll culture line, treatment with 5-aza-2'-deoxycytidine resulted in ree
xpression of the VHL gene. These findings suggest that aberrant methyl
ation of CpG islands may participate in the tumor-suppressor gene inac
tivations which initiate or cause progression of common human cancers.